DOUG BADGER

H.R. 1845 & S. 960, The Medicare IVIG Access Act, as they relate to Medicare reimbursement for certain drugs and biologicals, including Medicare coverage of services and supplies for home infusion of IVIG. H.R. 8, the American Taxpayer Relief Act, as it relates to sequestration, IVIG, Medicare physician payment and potential offsets. Issues pertaining to pedigree and downstream supply chain security. Issues related to survey and certification of dialysis facilities.

H.R. 1845 & S. 960, The Medicare IVIG Access Act, as they relate to Medicare reimbursement for certain drugs and biologicals, including Medicare coverage of services & supplies for home infusion of IVIG. H.R. 8, the American Taxpayer Relief Act, as it relates to sequestration, IVIG, Medicare physician payment and potential offsets. Issues related to survey and certification of dialysis facilities.

S. 2243 / H.R. 6232, Medicare Better Health Rewards Program Act, as it relates to providing wellness incentives to seniors. Issues related to healthy school lunches. Issues related to compounding of pharmaceuticals.

Issues involving healthy lifestyles for Medicare beneficiaries. S. 2243 / H.R. 6232, Medicare Better Health Rewards Program Act, as it relates to providing wellness incentives to seniors. H.R. 8, the American Taxpayer Relief Act and issues concerning Medicare hospital outpatient Evaluation and Management (E&M) reimbursement, IME, coding, and physician reimbursement. Issues involving new GME programs and cancer hospitals. Issues involving telehealth services.

Issues relating to Medicare Advantage, particularly pertaining to coverage of dual eligibles. H.R. 8, the American Taxpayer Relief Act & issues related to the extension of Medicare special needs plans.

H.R. 5856, FY 13 DOD Appropriations Act, as it relates to military dental research funding.

S. 1855, The Pandemic All-Hazards Preparedness Act (PAHPA) as it relates to dental emergency responders.

H.R. 5856, FY 13 DOD Appropriations Act, as it relates to military dental research funding. S. 3295, FY 13 Labor - HHS - Education approps bill, as it pertains to access to dental care.

Issues surrounding proposed demonstration project affecting dual eligibles, particularly as they relate to preventing disruption of care for those enrolled in MA plans.

Issues surrounding proposed demonstration project affecting dual eligibles, particularly as they relate to preventing disruption of care for those enrolled in MA plans. Implementation of health care reform law particularly as it pertains to ex-pat coverage, delivery system changes, and market flexibility.

Issues concerning the impact of sequestration and the continuing resolution on medical devise user fees.

Issues involving healthy lifestyles for Medicare beneficiaries. S. 2243 / H.R. 6232, Medicare Better Health Rewards Program Act, as it relates to providing wellness incentives to seniors. Issues concerning Medicare hospital outpatient Evaluation and Management (E&M) reimbursement, IME and the SGR.

S. 2243 / H.R. 6232, Medicare Better Health Rewards Program Act, as it relates to providing wellness incentives to seniors. Issues related to healthy school lunches.

H.R. 1845 & S. 960, The Medicare IVIG Access Act, as they relate to Medicare reimbursement for certain drugs and biologicals, including Medicare coverage of services & supplies for home infusion of IVIG. Issues related to survey and certification of dialysis facilities.

H.R. 1845 & S. 960, The Medicare IVIG Access Act, as they relate to Medicare reimbursement for certain drugs and biologicals, including Medicare coverage of services and supplies for home infusion of IVIG. Issues pertaining to pedigree and downstream supply chain security. Issues related to survey and certification of dialysis facilities.

Issues surrounding proposed demonstration project affecting dual eligibles, particularly as they relate to preventing disruption of care for those enrolled in MA plans.

Issues surrounding proposed demonstration project affecting dual eligibles, particularly as they relate to preventing disruption of care for those enrolled in MA plans. Implementation of health care reform law; delivery system and market flexibilty.

Issues concerning Part B drug reimbursement.

Issues relating to Medicare Advantage, particularly pertaining to coverage of dual eligibles. Issues related to Medicaid and coverage of dual eligibles.

Issues concerning the impact of the sequestration on prescription drug user fees.

Issues concerning the impact of sequestration and the continuing resolution on medical devise user fees.

Oppose legislative efforts to repeal authority granted to the Federal Reserve to prescribe regulations relating to swipe fees, including H.R. 3156, the Consumer Debit Card Protection Act.

Oppose legislative efforts to repeal authority granted to the Federal Reserve to prescribe regulations relating to swipe fees, including H.R. 3156, the Consumer Debit Card Protection Act.

H.R. 5856, FY 13 DOD Appropriations Act, as it relates to military dental research funding. S. 3295, FY 13 Labor - HHS - Education approps bill, as it pertains to access to dental care.

H.R. 5856, FY 13 DOD Appropriations Act, as it relates to military dental research funding.

Medicare reimbursement for hospice services. S. 722 / H.R. 3506, Hospice Evaluation and Legitimate Payment (HELP) Act, as it relates to hospice services under Medicare.

Medicare reimbursement for hospice services. S. 722 / H.R. 3506, Hospice Evaluation and Legitimate Payment (HELP) Act, as it relates to hospice services under Medicare.

H.R. 5856, FY 13 DOD Appropriations Act, as it relates to military dental research funding. S. 3295, FY 13 Labor - HHS - Education approps bill, as it pertains to access to dental care.

H.R. 5856, FY 13 DOD Appropriations Act, as it relates to military dental research funding. S. 3295, FY 13 Labor - HHS - Education approps bill, as it pertains to access to dental care.

Medicare reimbursement for hospice services. S. 722 / H.R. 3506, Hospice Evaluation and Legitimate Payment (HELP) Act, as it relates to hospice services under Medicare.

Medicare reimbursement for hospice services. S. 722 / H.R. 3506, Hospice Evaluation and Legitimate Payment (HELP) Act, as it relates to hospice services under Medicare.

IPPS reimbursement for hospitals and issues surrounding new GME programs. Issues involving healthy lifestyles for Medicare beneficiaries. S. 2243, Medicare Better Health Rewards Program Act, as it relates to providing wellness incentives to seniors. Issues concerning Medicare hospital outpatient Evaluation and Management (E&M) reimbursement.

H.R. 561, The Food and Drug Administration Reform Act of 2012, S. 3187, Food and Drug Administration Safety and Innovation Act as it pertains to hospital repackaging of drugs in shortage. S. 2243, Medicare Better Health Rewards Program Act, as it relates to providing wellness incentives to seniors.

S. 3215 / H.R. 5854, Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2013, as it relates to encouraging home dialysis in the VA health system.

H.R. 1845 & S. 960, The Medicare IVIG Access Act, as they relate to Medicare and Medicaid reimbursement for certain drugs and biologicals, including Medicare coverage of services and supplies for home infusion of IVIG. H.R. 561, The Food and Drug Administration Reform Act of 2012, S. 3187, Food & Drug Administration Safety and Innovation Act, as it pertains to drug safety, including "track & trace" provisions and drug shortages.

HR 1121 / S. 737, Responsible Consumer Financial Protection Regulations Act; H.R. 1667, Bureau of Consumer Financial Protection Transfer Clarification Act; H.R.1315, Consumer Financial Protection Safety and Soundness Improvement Act; H.R. 4014, To amend the Federal Deposit Insurance Act with respect to information provided to the CFPB, issues related to regulation of check cashing and other money services.

HR 1121 / S. 737, Responsible Consumer Financial Protection Regulations Act; H.R. 1667, Bureau of Consumer Financial Protection Transfer Clarification Act; H.R.1315, Consumer Financial Protection Safety and Soundness Improvement Act; H.R. 4014, To amend the Federal Deposit Insurance Act with respect to information provided to the CFPB, issues related to regulation of check cashing and other money services.

H.R. 2182 / S. 1734, Generating Antibiotic Incentives Now Act; H.R. 5651, Food and Drug Administration Reform Act of 2012, S.3187, Food and Drug Administration Safety and Innovation Act; issues pertaining to antibiotic incentives, drug safety pedigree, and drug supply chain.

HR 1121 / S. 737, Responsible Consumer Financial Protection Regulations Act; H.R. 1667, Bureau of Consumer Financial Protection Transfer Clarification Act; H.R.1315, Consumer Financial Protection Safety and Soundness Improvement Act; H.R. 4014, To amend the Federal Deposit Insurance Act with respect to information provided to the CFPB, issues related to regulation of check cashing and other money services.

HR 1121 / S. 737, Responsible Consumer Financial Protection Regulations Act; H.R. 1667, Bureau of Consumer Financial Protection Transfer Clarification Act; H.R.1315, Consumer Financial Protection Safety and Soundness Improvement Act; H.R. 4014, To amend the Federal Deposit Insurance Act with respect to information provided to the CFPB, issues related to regulation of check cashing and other money services.

H.R. 3211, Humanitarian Device Reform Act of 2011 - provisions relating to the improving of humanitarian device regulation and foster device development for rare diseases. S. 1865, Patient Access to Medical Innovation Act - provisions relating to the improving humanitarian device regulation and foster device development for rare diseases. H.R. 5651, Food and Drug Administration Reform Act of 2012, S. 3187, Food and Drug Administration Safety and Innovation Act, issues pertaining to medical devices.

Issues concerning Medicare Part D and B reimbursements.

H.R. 5651, Food and Drug Administration Reform Act of 2012 and S. 3187, Food and Drug Administration Safety and Innovation Act, provisions related to drug shortages; drug supply chain safety and reclassification.

Issues relating to Medicare Advantage, particularly pertaining to coverage of dual eligibles. Issues related to Medicaid and coverage of dual eligibles.

H.R. 561, Food and Drug Administration Reform Act of 2012 and S. 3187, Food and Drug Administration Safety and Innovation Act, provisions related to drug supply chain safety.

Oppose legislative efforts to repeal authority granted to the Federal Reserve to prescribe regulations relating to swipe fees, including H.R. 3156, the Consumer Debit Card Protection Act.

Oppose legislative efforts to repeal authority granted to the Federal Reserve to prescribe regulations relating to swipe fees, including H.R. 3156, the Consumer Debit Card Protection Act.

Issues surrounding proposed demonstration project affecting dual eligibles, particularly as they relate to preventing disruption of care for those enrolled in MA plans.

Issues surrounding proposed demonstration project affecting dual eligibles, particularly as they relate to preventing disruption of care for those enrolled in MA plans.

HR 1121 / S. 737, Responsible Consumer Financial Protection Regulations Act; H.R. 1667, Bureau of Consumer Financial Protection Transfer Clarification Act; H.R.1315, Consumer Financial Protection Safety and Soundness Improvement Act; H.R. 4014, To amend the Federal Deposit Insurance Act with respect to information provided to the CFPB, issues related to regulation of check cashing and other money services.

HR 1121 / S. 737, Responsible Consumer Financial Protection Regulations Act; H.R. 1667, Bureau of Consumer Financial Protection Transfer Clarification Act; H.R.1315, Consumer Financial Protection Safety and Soundness Improvement Act; H.R. 4014, To amend the Federal Deposit Insurance Act with respect to information provided to the CFPB, issues related to regulation of check cashing and other money services.

S. 722 / H.R. 3506, Hospice Evaluation and Legitimate Payment (HELP) Act, as it relates to Medicare reimbursement for hospice services. Medicare payment for hospice services. H.R. 3630, Middle Class Tax Relief and Job Creation Act, related to Medicare reimbursement for hospice care.

S. 722 / H.R. 3506, Hospice Evaluation and Legitimate Payment (HELP) Act, as it relates to Medicare reimbursement for hospice services. Medicare payment for hospice services. H.R. 3630, Middle Class Tax Relief and Job Creation Act, related to Medicare reimbursement for hospice care.

H.R. 3630, the Temporary Payroll Tax Cut Continuation Act; issues related to Medicare and Medicaid reimbursements; and issues pertaining to Part A Medicare reimbursements.

H. Con Res 112, FY 2013 Budget Resolution.

H.R. 3211, Humanitarian Device Reform Act of 2011 - provisions relating to the improving of humanitarian device regulation and foster device development for rare diseases. S. 1865, Patient Access to Medical Innovation Act - provisions relating to the improving humanitarian device regulation and foster device development for rare diseases. H.R. 3209, Premarket Predictability Act of 2011 - provisions relating to a new streamlined review of new devices, require reviewers to provide scientific or regulatory rationale for major decisions and establish an expedited approval appellate process, and the establishment of the two Investigational Device Exemption pathways. H.R. 3203, Novel Device Regulatory Relief Act of 2011 - provisions relating to the streamlining the de novo classification process by striking the requirement that an applicant submit a 510(k) application before entering the de novo process. H.R. 3206, Cultivating Scientific Expertise to Foster Innovation for Patients Act of 2011 - provisions relating to the fixing of the FDA's conflict of interest policies to ensure the most knowledgeable experts are able to serve on FDA advisory committees.

FY 2013 VA approps legislation as it relates to encouraging home dialysis in the VA health system.

H.R. 1845 & S. 960, The Medicare IVIG Access Act, as they relate to Medicare and Medicaid reimbursement for certain drugs and biologicals, including Medicare coverage of services & supplies for home infusion of IVIG. H.R.3630, Middle Class Tax Relief and Job Creation Act, as it relates to Medicare and Medicaid reimbursement for certain drugs and biologicals.

H.R. 1845 & S. 960, The Medicare IVIG Access Act, as they relate to Medicare and Medicaid reimbursement for certain drugs and biologicals, including Medicare coverage of services and supplies for home infusion of IVIG. Issues related to drug safety & drug shortages. Discussion draft legislation reauthorizing user fees for drugs and devices, as it relates to drug safety & drug shortages. H.R.3630, Middle Class Tax Relief and Job Creation Act, as it relates to Medicare and Medicaid reimbursement for certain drugs and biologicals.

Military dental research funding.

FY 13 DOD Appropriations bill as it relates to military dental research funding.

Discussion draft legislation reauthorizing user fees for drugs & devices, as it relates to drug shortages. Issues involving research on mesenchymal stem cell transplantation. S. 2243, Medicare Better Health Rewards Program Act, as it relates to providing wellness incentives to seniors.

IPPS reimbursement for hospitals and issues surrounding new GME programs. Issues involving healthy lifestyles for Medicare beneficiaries. H.R. 3630, Middle Class Tax Relief and Job Creation Act, issues concerning Medicare reimbursement for hospitals and physicians. S. 2243, Medicare Better Health Rewards Program Act, as it relates to providing wellness incentives to seniors.

H.Con.Res. 112, Fiscal Year 2013 Budget Resolution and issues related to Medicare.

Issues concerning the reauthorization of the Prescription Drug User Fee Act including drug shortages & drug supply chain safety.

Issues concerning Medicare Part D and B reimbursements.

Issues relating to Medicare Advantage, particularly pertaining to coverage of dual eligibles. Issues related to Medicaid and coverage of dual eligibles; H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2012 and issues concerning Medicare reimbursement.

H.Con.Res. 112, Fiscal Year 2013 Budget Resolution and issues pertaining to Medicare.

Oppose legislative efforts to repeal authority granted to the Federal Reserve to prescribe regulations relating to swipe fees, including H.R. 3156, the Consumer Debit Card Protection Act.

Oppose legislative efforts to repeal authority granted to the Federal Reserve to prescribe regulations relating to swipe fees, including H.R. 3156, the Consumer Debit Card Protection Act.

H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2012 and issues concerning Medicare reimbursement for diabetes supplies; issues concerning Medicare auditing practices and issues related to DMEPOS competitive bidding.

Issues surrounding proposed demonstration project affecting dual eligibles, particularly as they relate to preventing disruption of care for those enrolled in MA plans.

Issues surrounding proposed demonstration project affecting dual eligibles, particularly as they relate to preventing disruption of care for those enrolled in MA plans.

H.R. 3630, Middle Class Tax Relief & Job Creation Act, as it relates to Medicare & Medicaid reimbursement for drugs & biologicals.

H.R. 3630, Middle Class Tax Relief & Job Creation Act, as it relates to Medicare & Medicaid reimbursement for drugs & biologicals.

H.R. 3630, Middle Class Tax Relief & Job Creation Act, as it relates to Medicare & Medicaid reimbursement for drugs & biologicals.

HR 1121 / S. 737, Responsible Consumer Financial Protection Regulations Act; H.R. 1667, Bureau of Consumer Financial Protection Transfer Clarification Act; H.R.1315, Consumer Financial Protection Safety and Soundness Improvement Act; H.R. 4014, To amend the Federal Deposit Insurance Act with respect to information provided to the CFPB, issues related to regulation of check cashing and other money services.

HR 1121 / S. 737, Responsible Consumer Financial Protection Regulations Act; H.R. 1667, Bureau of Consumer Financial Protection Transfer Clarification Act; H.R.1315, Consumer Financial Protection Safety and Soundness Improvement Act; H.R. 4014, To amend the Federal Deposit Insurance Act with respect to information provided to the CFPB, issues related to regulation of check cashing and other money services.

Medicare reimbursement issues concerning coverage of prescription drugs.

Medicare reimbursement issues concerning coverage of prescription drugs.

Medicare reimbursement issues concerning coverage of prescription drugs.

Fairer credit card interchange fees.

Fairer credit card interchange fees.

Fairer credit card interchange fees.

IPPS reimbursement for hospitals and issues surrounding new GME programs. Issues involving healthy lifestyles for Medicare beneficiaries. H.R. 3765 / H.R. 3630, Temporary Payroll Tax Cut Continuation Act, issues concerning Medicare reimbursement for hospitals.

Oppose legislative efforts to delay Federal Reserve rules regarding debit card interchange fees, including HR 1081, the Consumers Payment System Protection Act, and S. 575, the Debit Interchange Fee Study Act.

Oppose legislative efforts to delay Federal Reserve rules regarding debit card interchange fees, including HR 1081, the Consumers Payment System Protection Act, and S. 575, the Debit Interchange Fee Study Act.

H.R. 3630, Temporary Payroll Tax Cut Continuation Act, as it relates to Medicare & Medicaid reimbursement for drugs & biologicals.

S. 365, the Budget Control Act, as it relates to Medicare & Medicaid reimbursement for drugs & biologicals.

H.R. 3630, Temporary Payroll Tax Cut Continuation Act, as it relates to Medicare & Medicaid reimbursement for drugs & biologicals.

Issues relating to Medicare Advantage, particularly pertaining to coverage of dual eligibles. Issues related to Medicaid and coverage of dual eligibles; H.R. 3630 and H.R. 3765, Temporary Payroll Tax Cut Continuation Act and issues concerning Medicare reimbursement.

H.R. 3630 and H.R. 3765, Temporary Payroll Tax Cut Continuation Act and issues concerning Medicare reimbursement for diabetes supplies; issues concerning Medicare auditing practices and issues related to DMEPOS competitive bidding.

H.R. 3630 & H.R. 3765, Temporary Payroll Tax Cut Continuation Act and issues related to Medicare reimbursements.

Device related FDA issues including user fee re-authorization & the 510(K) process; physician owned distributorships; S. 1865, The Patient Access to Medical Innovation Act and H.R. 3211, Humanitarian Device Reform Act; issues concerning the implementation of the Sunshine Act.

H.R. 3630, Temporary Payroll Tax Cut Continuation Act and H.R. 3765, Temporary Payroll Tax Cut Continuation Act and issues pertaining to Medicare reimbursement.

Military dental research funding.

S.1599 / H.R. 3671, FY 12 Labor-HHS Approps bills as they relate to a prohibition on funding for an alternative dental provider demonstration program. H.R. 3671 & H.R. 2219, FY 12 DOD Appropriations bill as it relates to military dental research funding.

H.R. 1845 & S. 960, The Medicare IVIG Access Act, as they relate to Medicare and Medicaid reimbursement for certain drugs and biologicals, including Medicare coverage of services and supplies for home infusion of IVIG. Issues related to drug safety & drug shortages. H.R. 3630, Temporary Payroll Tax Cut Continuation Act, as it relates to Medicare and Medicaid reimbursement for certain drugs and biologicals. Issues related to pandemic preparedness.

H.R. 1845 & S. 960, The Medicare IVIG Access Act, as they relate to Medicare and Medicaid reimbursement for certain drugs and biologicals, including Medicare coverage of services & supplies for home infusion of IVIG. H.R. 3630, Temporary Payroll Tax Cut Continuation Act, as it relates to Medicare and Medicaid reimbursement for certain drugs and biologicals.

Oppose application of FDA menu labeling requirements to grocers.

Hospice programs as they related to services available to veterans.

S. 722 / H.R. 3506, Hospice Evaluation and Legitimate Payment (HELP) Act, as it relates to Medicare reimbursement for hospice services. Medicare payment for hospice services. H.R. 3630, Temporary Payroll Tax Cut Continuation Act, related to Medicare reimbursement for hospice care.

S. 722 / H.R. 3506, Hospice Evaluation and Legitimate Payment (HELP) Act, as it relates to Medicare reimbursement for hospice services. Medicare payment for hospice services. H.R. 3630, Temporary Payroll Tax Cut Continuation Act, related to Medicare reimbursement for hospice care.

Oppose application of FDA menu labeling requirements to grocers.

HR 1121 / S. 737, Responsible Consumer Financial Protection Regulations Act; H.R. 1667, Bureau of Consumer Financial Protection Transfer Clarification Act, issues related to regulation of check cashing and other money services.

HR 1121 / S. 737, Responsible Consumer Financial Protection Regulations Act; H.R. 1667, Bureau of Consumer Financial Protection Transfer Clarification Act, issues related to regulation of check cashing and other money services.

Regulatory issues on PPACA implementation as they relate to ex-pat plans, medical loss ratio, annual limits, limited benefit plans, grandfather provisions, reinsurance for early retiree plans, and pre-existing condition exclusions.

IPPS reimbursement for hospitals and issues surrounding new GME programs. Issues involving healthy lifestyles for Medicare beneficiaries.

S. 365, The Budget Control Act and issues pertaining to Medicaid reimbursement.

Oppose application of FDA menu labeling requirements to grocers.

Oppose legislative efforts to delay Federal Reserve regarding debit card interchange fees, including H.R. 1081, the Consumers Payment System Protection Act, and S. 575, the Debit Interchange Fee Study Act.

Oppose legislative efforts to delay Federal Reserve regarding debit card interchange fees, including H.R. 1081, the Consumers Payment System Protection Act, and S. 575, the Debit Interchange Fee Study Act.

Oppose application of FDA menu labeling requirements to grocers.

Oppose legislative efforts to delay Federal Reserve regarding debit card interchange fees, including H.R. 1081, the Consumers Payment System Protection Act and S. 575, the Debit Interchange Fee Study Act.

Oppose legislative efforts to delay Federal Reserve regarding debit card interchange fees, including H.R. 1081, the Consumers Payment System Protection Act and S. 575, the Debit Interchange Fee Study Act.

Device related FDA issues including user fee re-authorization & the 510(K) process; physician owned distributorships; issues pertaining to Congressional Oversight inquiry from the Senate Finance Committee.

S. 365, The Budget Control Act as it relates to Medicare reimbursement.

S. 365, The Budget Control Act as it relates to Medicare reimbursement.

Issues relating to Medicare Advantage, particularly pertaining to coverage of dual eligibles. Issues related to Medicaid and coverage of dual elegibles.

S. 365, The Budget Control Act and issues pertaining to Medicare, Medicaid and dual eligibles.

S. 365, The Budget Control Act and issues pertaining to sequestration and mandatory spending in federal programs.

Device related FDA issues including user fee re-authorization & the 510(K) process; physician owned distributorships; issues pertaining to Congressional Oversight inquiry from the Senate Finance Committee.

S. 365, The Budget Control Act as it relates to Medicare reimbursement.

S. 365, The Budget Control Act as it relates to Medicare reimbursement.

Regulatory issues on PPACA implementation as they relate to ex-pat plans, medical loss ratio, annual limits, limited benefit plans, grandfather provisions, reinsurance for early retiree plans, and pre-existing condition exclusions.

Issues concerning Medicare reimbursement for diabetes supplies; Issues concerning Medicare auditing practices; Issues related to DMEPOS competitive bidding.

S. 365, The Budget Control Act and issues concerning Medicare and Medicaid reimbursements for DME.

H.R. 1845 & S. 960, The Medicare IVIG Access Act, as they relate to Medicare and Medicaid reimbursement for certain drugs and biologicals, including Medicare coverage of services and supplies for home infusion of IVIG. Issues related to drug safety & drug shortages. S. 365, the Budget Control Act, as it relates to Medicare and Medicaid reimbursement for certain drugs and biologicals. Issues related to pandemic preparedness.

S. 365, the Budget Control Act, as it relates to Medicare and Medicaid reimbursement for certain drugs and biologicals.

H.R. 1845 & S. 960, The Medicare IVIG Access Act, as they relate to Medicare and Medicaid reimbursement for certain drugs and biologicals, including Medicare coverage of services & supplies for home infusion of IVIG. S. 365, the Budget Control Act, as it relates to Medicare and Medicaid reimbursement for certain drugs and biologicals.

S. 365, The Budget Control Act & issues pertaining to Medicare reimbursements.

Oppose legislative efforts to delay Federal Reserve rules regarding debit card interchange fees, including HR 1081, the Consumers Payment System Protection Act, and S. 575, the Debit Interchange Fee Study Act.

Oppose legislative efforts to delay Federal Reserve rules regarding debit card interchange fees, including HR 1081, the Consumers Payment System Protection Act, and S. 575, the Debit Interchange Fee Study Act.

S. 365, the Budget Control Act, as it relates to Medicare & Medicaid reimbursement for drugs & biologicals.

S. 365, the Budget Control Act, as it relates to Medicare & Medicaid reimbursement for drugs & biologicals.

S. 365, the Budget Control Act, as it relates to Medicare & Medicaid reimbursement for drugs & biologicals.

S.1599, no House bill number, FY 12 Labor-HHS Approps bills as they relate to a prohibition on funding for an alternative dental provider demonstration program. H.R. 2219, FY 12 DOD Appropriations bill as it relates to military dental research funding. S. 365, the Budget Control Act, as it relates to dentistry.

Oppose legislative efforts to delay Federal Reserve rules regarding debit card interchange fees, including HR 1081, the Consumers Payment System Protection Act, and S. 575, the Debit Interchange Fee Study Act.

Oppose legislative efforts to delay Federal Reserve rules regarding debit card interchange fees, including HR 1081, the Consumers Payment System Protection Act, and S. 575, the Debit Interchange Fee Study Act.

S. 722, Hospice Evaluation and Legitimate Payment (HELP) Act, as it relates to Medicare reimbursement for hospice services. Medicare payment for hospice services.

HR 1121 / S. 737, Responsible Consumer Financial Protection Regulations Act; H.R. 1667, Bureau of Consumer Financial Protection Transfer Clarification Act, issues related to regulation of check cashing and other money services.

HR 1121 / S. 737, Responsible Consumer Financial Protection Regulations Act; H.R. 1667, Bureau of Consumer Financial Protection Transfer Clarification Act, issues related to regulation of check cashing and other money services.

Credit card swipe fees. FDA menu labeling requirements.

Credit card swipe fees. FDA menu labeling requirements.

Credit card swipe fees. FDA menu labeling requirements.

Credit card swipe fees. FDA menu labeling requirements.

Credit card swipe fees. FDA menu labeling requirements.

Credit card swipe fees. FDA menu labeling requirements.

H.R. 1, Full Year Continuing Appropriations Act of 2011 and H.R. 1473, DOD and Full-Year Continuing Appropriations Act, as they relate to BARDA funding.

H.R. 1845 & S. 960, The Medicare IVIG Access Act, as they relate to Medicare and Medicaid reimbursement issues for certain drugs and biologicals, including Medicare coverage of services & supplies for home infusion of IVIG.

H.R. 1845 & S. 960, The Medicare IVIG Access Act, as they relate to Medicare and Medicaid reimbursement issues for certain drugs and biologicals, including Medicare coverage of services and supplies for home infusion of IVIG. Issues related to drug safety & drug shortages.

Regulatory issues on PPACA implementation as they relate to medical loss ratio, annual limits, limited benefit plans, grandfather provisions, reinsurance for early retiree plans, and pre-existing condition exclusions.

H. Con Res 34, fiscal year 2012 budget resolution, issues pertaining to Medicare Advantage, Medicaid and dual eligibles.

Issues relating to Medicare Advantage, particularly pertaining to coverage of dual eligibles. Issues related to Medicaid and coverage of dual elegibles.

H. Con Res 34, fiscal year 2012 budget resolution, issues pertaining to health care reform and Medicare reimbursements for hospitals.

Oppose legislative efforts to delay Federal Reserve rules regarding debit card interchange fees, including HR 1081, the Consumers Payment System Protection Act, and S. 575, the Debit Interchange Fee Study Act.

Oppose legislative efforts to delay Federal Reserve rules regarding debit card interchange fees, including HR 1081, the Consumers Payment System Protection Act, and S. 575, the Debit Interchange Fee Study Act.

Issues concerning medical device distributorships.

Issues concerning the 510(K) process; group purchasing organizations.

H. Con Res 34, fiscal year 2012 budget resolution, issues concerning Medicare and health reform.

Issues relating to antibiotics and antimicrobial resistance.

Issues relating to Medicare coverage of home infusion services; issues concerning accountable care organizations; hospital acquired infections.

Issues concerning Medicare waste, fraud & abuse as it relates to diabetes supplies; H.R. 1041, Fairness in Medicare Bidding Act as it relates to DMEPOS competitive bidding; Issues concerning Medicare reimbursement for diabetes supplies; Issues concerning Medicare auditing practices.

H Con Res 34, fiscal year 2012 budget resolution, as it relates to Medicare and Health Care Reform.

IPPS reimbursement for hospitals and issues surrounding new GME programs.

H.R. 5, Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011.

H.R. 1, Full-Year Continuing Appropriations Act of 2011 and H.R. 1473, DOD and Full-Year Continuing Appropriations Act, as they relate to a prohibition on funding for an alternative dental provider demonstration program and military dental research monies. FY'12 Senate DOD Appropriations Bills as it relates to military dental research monies.

IPPS reimbursement for hospitals and issues surrounding new GME programs.

H Con Res 37 as it relates to Medicare and Health Care Reform.

Oppose legislative efforts to delay Federal Reserve rules regarding debit card interchange fees, including HR 1081, the Consumers Payment System Protection Act, and S. 575, the Debit Interchange Fee Study Act.

Oppose legislative efforts to delay Federal Reserve rules regarding debit card interchange fees, including HR 1081, the Consumers Payment System Protection Act, and S. 575, the Debit Interchange Fee Study Act.

S. 722, Hospice Evaluation and Legitimate Payment (HELP) Act, as it relates to Medicare reimbursement for hospice services. Medicare payment for hospice services.

Wyden-Roberts bill (S. 722, Hospice Evaluation and legitimate Payment Act) and all issues involving Medicare and Medicaid payment to hospices.

Wyden-Roberts bill (S. 722, Hospice Evaluation and legitimate Payment Act) and all issues involving Medicare and Medicaid payment to hospices.

Wyden-Roberts bill (S. 722, Hospice Evaluation and legitimate Payment Act) and all issues involving Medicare and Medicaid payment to hospices.

HR 1121 / S. 737, Responsible Consumer Financial Protection Regulations Act; H.R. 1667, Bureau of Consumer Financial Protection Transfer Clarification Act, issues related to regulation of check cashing and other money services.

HR 1121 / S. 737, Responsible Consumer Financial Protection Regulations Act; H.R. 1667, Bureau of Consumer Financial Protection Transfer Clarification Act, issues related to regulation of check cashing and other money services.

Issues related to electricity transmission planning, siting authority, and cost allocation.

Issues related to electricity transmission planning, siting authority, and cost allocation.

Issues related to interchange credit card fees.

Oppose legislative efforts to delay Federal Reserve rules regarding debit card interchange fees, including HR 1081, the Consumers Payment System Protection Act, and S. 575, the Debit Interchange Fee Study Act.

Regulatory issues on PPACA implementation as they relate to medical loss ratio, annual limits, limited benefit plans, grandfather provisions, reinsurance for early retiree plans, and pre-existing condition exclusions.